Skip to main content
Log in

Infliximab reduces resource use and costs in Crohn's disease

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. National Health Service

Reference

  • Lindsay JO, et al. A UK retrospective observational study of clinical outcomes and healthcare resource utilisation of infliximab treatment in Crohn's disease. Alimentary Pharmacology and Therapeutics : 23 May 2013. Available from: URL: http://dx.doi.org/10.1111/apt.12339

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Infliximab reduces resource use and costs in Crohn's disease. PharmacoEcon Outcomes News 681, 3 (2013). https://doi.org/10.1007/s40274-013-0499-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0499-y

Navigation